Passive immunotherapy in Sars-Cov2 infections

This article presents the current situation by November 2021 of the prophylactic or therapeutical use of polyclonal or monoclonal antibodies in Covid-19, either as immuno-modulators, or directly directed towards the virus.

Saved in:

Bibliographic Details
Published in:	Virologie (Montrouge, France) Vol. 25; no. 6; p. 324
Main Authors:	Christodoulou, Ioanna, Cohen, Jacques H M
Format:	Journal Article
Language:	French
Published:	France 01-12-2021
Subjects:	Antibodies, Neutralizing COVID-19 Humans Immunization, Passive RNA, Viral SARS-CoV-2
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	This article presents the current situation by November 2021 of the prophylactic or therapeutical use of polyclonal or monoclonal antibodies in Covid-19, either as immuno-modulators, or directly directed towards the virus.
ISSN:	1267-8694
DOI:	10.1684/vir.2021.0922